Close menu

September 28th, 2022 | 11:22 CEST

Time for bargain hunters? Plug Power, Varta and Pathfinder Ventures

  • Investments
  • Camping
  • RV
  • Electromobility
Photo credits:

Growth stocks are currently under particular pressure. But this can also create opportunities for bargain hunters. Perhaps in the case of Varta? The share has crashed sharply after a profit warning. Now, the first analyst has upgraded the share from "sell" to "buy". But even his reasoning does not sound like a new growth story. Plug Power also tends to live on the hope of growth. While the new production facility is technically a milestone, it needs more. In contrast, things are going well at Pathfinder Ventures. The still unknown tourism company is profiting from the camping boom in North America, and its valuation is anything but expensive.

time to read: 3 minutes | Author: Fabian Lorenz

Table of contents:

    Joe Bleackley, CEO, Pathfinder Ventures Inc.
    "[...] In addition to campsite fees, Pathfinder Ventures has put itself in a position to offer all of these sought-after camping solutions. The only thing they don't sell is the RV itself. [...]" Joe Bleackley, CEO, Pathfinder Ventures Inc.

    Full interview


    Pathfinder Ventures: An exotic company with price potential

    What stockbroker doesn't want to discover a growth story before the masses do? One candidate for that is Pathfinder Ventures. The Company is currently building a network of upscale, family-friendly campgrounds and RV parks in western Canada. In doing so, it is capitalizing on the trend toward self-directed vacations in the great outdoors. Pathfinder is only at the beginning of its growth and investment phase. Still, the operating result is already profitable at this early stage - especially important in the environment of rising interest rates. There is plenty of growth potential for the coming years. The camping market in Canada alone is worth CAD 2.3 billion - and expansion into the US should not be a major problem.

    In the second quarter of 2022, Pathfinder Ventures increased revenue 81% YOY to about CAD 917,000. Despite high investments, operating earnings before interest, taxes, depreciation and amortization (EBITDA) were significantly improved from CAD -398,120 to CAD 54,395. The net loss was also reduced. Currently, Pathfinder Ventures operates three sites. The Agassiz site was acquired in the second quarter of 2022 and is already being expanded. In addition, the Company plans three more acquisitions through 2023 - one of which may occur this year. At the end of the second quarter, the Company had cash on hand of CAD 1.58 million. In the current year, revenue is expected to increase to CAD 3.1 million. With a market capitalization of around CAD 4 million, Pathfinder is a microcap, but is anything but expensive.

    Plug Power: Hydrogen from offshore wind power

    Germany is not the only country with high hopes for hydrogen as a substitute for natural gas. The technology of the future is also being promoted worldwide. This is necessary because the technology is not yet ready for mass production. But what can be in the future is shown once again by Plug Power. The hydrogen pure play, together with partner Lhyfe, has commissioned the first hydrogen production plant on a floating platform. Why on the sea? Because it allows the 1 MW plant to be in the immediate vicinity of an offshore wind farm and produce green hydrogen. The plant was built off the French Atlantic coast and serves as a test for further projects by Plug Power and Lhyfe. The two partners plan to jointly build green hydrogen production facilities across Europe. Production capacity is expected to reach 300 MW as early as 2025. They also plan to develop a 1-GW production facility jointly. Plug Power's stock has not been able to benefit from the news. It has corrected significantly in recent days and is currently trading at around EUR 23. According to, Plug Power is recommended as a buy by 12 analysts, while 7 advise a hold. There is currently no sell recommendation. The average price target is USD 34.24.

    Varta: Has the time come for bargain hunters?

    After the crash of the Varta share, has the time come for bargain hunters? At least the analysts of Warburg seem to be of this opinion. Thus, they have upgraded the share of the battery specialist from "Sell" to "Buy". The price target is EUR 53. However, the reasoning seems a bit thin: Although no positive newsflow is expected, for the time being, negative developments should now be priced in. A growth story looks different. DZ Bank also sees it that way. "The renewed failure to meet the targets the Company has set itself is likely to weigh on the share price in the short and medium term," said the analysts. They added that the medium-term sales target of EUR 1.3 billion to EUR 1.4 billion in 2024 is also unlikely to be achieved. The business with large-format batteries for electric cars will only contribute to sales from the end of 2024. With a target price of EUR 40, the analysts see little upside potential. The share certificates are currently trading at 35%. Thus, even the presentation of Bernard Wolf, Head of Investor Relations of Varta, at yesterday's 4th IIF investor conference ( could not provide new hope. The fact that Varta has revised its previous forecasts but has not published any new target figures is likely to cause uncertainty among investors. It leaves plenty of room for speculation, and stock market players do not like this.

    Even if the current price level appears attractive for bargain hunters, the growth fantasy is out of Varta for the time being. Plug Power is one of the leading companies in the hydrogen sector, but it needs more than just 1 MW plants to justify the high valuation. The valuation at Pathfinder Ventures is anything but high, but if the Company delivers on its growth targets, it could be worthwhile for investors.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author

    Related comments:

    Commented by André Will-Laudien on September 22nd, 2023 | 07:20 CEST

    Recalculation! These are the bare figures: TUI, Saturn Oil + Gas, Deutsche Bank - Buy prices non-stop!

    • Mining
    • Oil
    • travel
    • Investments
    • Banking

    Companies do not always have good figures in their baggage. Analysts listen very carefully to the words of those in charge. Often, it is only a minor sentence that changes entire valuations. TUI is slowly approaching pre-COVID figures. Saturn Oil & Gas must backtrack slightly because of substantial forest fires in Alberta, and Deutsche Bank aims to finalize the Postbank project in 2023. All three stocks offer good buying opportunities because the long-term prospects are quite convincing.


    Commented by Juliane Zielonka on September 22nd, 2023 | 06:50 CEST

    Cardiol Therapeutics, BioNTech, BYD - At top speed to new markets

    • Biotechnology
    • Pharma
    • Electromobility

    Cardiol Therapeutics is enjoying a remarkable development. The biotech company is now rolling out its ARCHER patient recruitment trial internationally at 35 participating centers. This accelerates research in the development of their therapy to combat myocarditis, a heart inflammation which has been associated with COVID-19 vaccination. For Cardiol Therapeutics, this represents an opportunity to get its therapy approved as an orphan drug. Approval is also at stake for BioNTech. With a multimillion-dollar funding boost, the Company is working on accelerated approval for a vaccine against a virus that caused quite a stir last year. The shortened development time is likely to impress investors. While business nations agree on fighting viruses, they disagree on commodities for the road. The EU would prefer to restrict BYD's successful sales on domestic roads - by imposing tariffs. BYD, meanwhile, is tapping into a completely different market.


    Commented by Nico Popp on September 21st, 2023 | 07:00 CEST

    Turnaround cancelled? Where 100% is possible: Varta, BYD, Manuka Resources

    • Mining
    • Vanadium
    • PreciousMetals
    • Batteries
    • Electromobility

    When soccer players move to a better team, it usually comes with higher earnings. Sometimes, the training is more intense, and the tasks off the pitch are more extensive. It is no longer comparable to the idyllic life at their former club. Athletes are then faced with the question, "Give up or bite the bullet?" The situation is similar for battery pioneer Varta, which is implementing its e-car plans with Porsche, of all companies. The sports car manufacturer offers major growth opportunities but is also considered meticulous among engineers. We highlight Varta's stock, take a look at BYD and outline opportunities at a company many have never heard of!